Home pfizer
 

Keywords :   


Tag: pfizer

Which Biotech Stock Should Pfizer, Inc. Buy?

2015-02-08 14:28:13| Biotech - Topix.net

Earlier this week, Pfizer announced that it would acquire Hospira , the top provider of injectable drugs. The deal will net Pfizer an intriguing biosimilar program, but some suspect that the company is still hungry for more.

Tags: buy stock biotech pfizer

 

Pfizer buying Hospira for about $15.23 billion

2015-02-05 14:25:12| Biotech - Topix.net

In this May 4, 2014 file photo, the Pfizer logo is displayed on the exterior of a former Pfizer factory in the Brooklyn borough of New York.

Tags: buying billion pfizer hospira

 
 

Pfizer Receives U.S. FDA Accelerated Approval Of IBRANCE (palbociclib)

2015-02-04 06:14:13| drugdiscoveryonline Home Page

Pfizer Inc. recently announced the U.S. Food and Drug Administration (FDA) has granted accelerated approval of IBRANCE (palbociclib), in combination with letrozole, for the treatment of postmenopausal women with estrogen receptor-positive, human epidermal growth factor receptor 2-negative (ER+/HER2-) advanced breast cancer as initial endocrine-based therapy for their metastatic disease

Tags: approval receives accelerated fda

 

FDA approves Pfizer drug to treat breast cancer in postmenopausal women

2015-02-04 01:08:56| Biotech - Topix.net

U.S. federal health regulators on Tuesday approved a highly anticipated medicine from Pfizer Inc. to treat postmenopausal women with a certain type of advanced breast cancer who have not already taken other drugs. The Food and Drug Administration approved Ibrance for women who have tumors that do not contain a protein known as HER-2.

Tags: women drug cancer treat

 

Pfizer net down on lower sales, higher research, legal costs

2015-01-27 15:37:07| Biotech - Topix.net

Pfizer Inc.'s fourth-quarter profit fell by half as worsening generic competition and unfavorable currency rates reduced sales, and higher research spending and legal costs also hurt the bottom line. The world's second-biggest drugmaker by revenue reported lower sales for most of its huge portfolio of prescription medicines, with the biggest hit coming from new generic competition to popular painkiller Celebrex.

Tags: net research legal sales

 

Sites : [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] next »